Results 11 to 20 of about 43,558 (239)

CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations [PDF]

Clinical Chemistry, 2010
BACKGROUND About 20% of women with ovarian cancer have low concentrations of serum cancer antigen 125 (CA125), and this important tumor marker cannot be used to monitor their disease. The measured concentration for mucin 1 (MUC1), or CA15-3, another tumor marker, can be lowered in breast and ovarian cancer patients ...
Cramer, Daniel, O'Rourke, D. J., Vitonis, A. F., Matulonis, Ursula, DiJohnson, D. A., Sluss, Patrick M., Crum, Christopher, Liu, B. C.- S.   +7 more
openaire   +3 more sources

CA125 Expression in Epithelioid Sarcoma [PDF]

Japanese Journal of Clinical Oncology, 2004
There has been no report on useful immunohistological markers for epithelioid sarcoma (ES) so far. The purpose of this study is to evaluate the positivity and specificity of CA125 as a marker for the correct diagnosis of ES.This study was performed in 11 patients with ES (nine men and two women; distal type: 10 cases; proximal type: one case), 78 ...
Hiroshi, Kato, Masahito, Hatori, Shoichi, Kokubun, Mika, Watanabe, Richard A, Smith, Tetsuo, Hotta, Akira, Ogose, Tetsuro, Morita, Takashi, Murakami, Setsuya, Aiba   +9 more
openaire   +2 more sources

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses [PDF]

, 2011
Background: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy.
Burges, Alexander, Fuerst, Sophie, Hertlein, Linda, Hofmann, Karin, Kirschenhofer, Angela, Krocker, Katja, Lenhard, Miriam, Mayr, Doris, Nagel, Dorothea, Stieber, Petra   +9 more
core   +1 more source

Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling [PDF]

, 2010
Objectives: Our objective was to test the performance of CA125 in classifying serum samples from a cohort of malignant and benign ovarian cancers and age-matched healthy controls and to assess whether combining information from matrix-assisted laser ...
Burford, Brian, Camuzeaux, Stephane, Cramer, Rainer Karl, Devetyarov, Dmitry, Ford, Jeremy, Gammerman, Alex, Gentry-Maharaj, Aleksandra, Jacobs, Ian, Luo, Zhiyuan, Menon, Usha, Nouretdinov, Iilia, Smith, Celia Jennifer, Timms, John F., Tiss, Ali   +13 more
core   +1 more source

Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients [PDF]

Journal of Medical Biochemistry
Background: It is an important clinical means to identify benign and malignant breast diseases caused by nipple discharge through the detection and analysis of components in nipple discharge.
Geng Jun, Jinli Shi, Guo Weina, Li Haiyan, Dan Yang, Gao Yan   +5 more
doaj   +1 more source

Improved early detection of ovarian cancer using longitudinal multimarker models [PDF]

, 2019
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the ...
Blyuss, Oleg, Gentry-Maharaj, Aleksandra, Gunu, Richard, Jacobs, Ian, Kalsi, Jatinderpal, Menon, Usha, Ryan, Andy, Timms, John F., Whitwell, Harry J., Worthington, Jenny, Zaikin, Alexey   +10 more
core   +3 more sources

The role of CA125 in clinical practice [PDF]

Journal of Clinical Pathology, 2005
Background: CA125 is a high molecular weight glycoprotein, which is expressed by a large proportion of epithelial ovarian cancers. The sensitivity and specificity of CA125 are poor and there are no guidelines produced by the Royal College of Pathologists or the Association of Clinical Biochemists to aid ...
E L, Moss, J, Hollingworth, T M, Reynolds   +2 more
openaire   +2 more sources

HE4 in the differential diagnosis of ovarian masses [PDF]

, 2015
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries.
ANASTASI, Emanuela, ANGELONI, Antonio, Flavia Longo, MANGANARO, Lucia, PORPORA, Maria Grazia, Teresa Granato   +5 more
core   +1 more source

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020

Cancer Management and Research, 2021
Qiang Yi, Yu Ran, Cong Li Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Cong Li No.
Yi Q, Ran Y, Li C
doaj  

Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors [PDF]

, 2009
Background: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT).
Burges, Alexander, Friese, Klaus, Hertlein, Linda, Kirschenhofer, Angela, Lenhard, Miriam S., Mayr, Doris, Nagel, Dorothea, Nehring, Stefanie, Stieber, Petra   +8 more
core   +1 more source